Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2009 by National Cancer Center, Korea.
Recruitment status was Recruiting

Study NCT00980603 Information provided by National Cancer Center, Korea

First Received on September 18, 2009. No Changes Posted

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Gastric Cancer

Additional conditions recognized in this trial

Stomach Neoplasms

More general conditions related to this trial

Interventions listed in this trial

docetaxel
docetaxel, cisplatin
docetaxel, S-1

Additional drug interventions recognized in this trial

Cisplatin

More general drug interventions related to this trial

Sponsors listed in this trial